Description
| Product Name | Details | CAT.No | Size |
| Fructosamine | Suitable for Hitachi 917 | HIT0591B | R1: 2 x 6ml R2: 2 x 14ml |
| Fructosamine | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0591C | R1: 3 x 6ml R2: 3 x 14ml |
| Fructosamine | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF591A | R1: 4 x 19.8ml R2: 4 x 6.9ml |
Product Description
The Biorex Diagnostics Fructosamine Assay is an in vitro diagnostic test for the quantitative determination of fructosamine in human serum and plasma. Fructosamine represents glycated serum proteins and provides an indicator of average blood glucose levels over the previous 2–3 weeks. This makes it a valuable tool for short-term monitoring of glycaemic control, particularly in situations where longer-term markers may not accurately reflect changes in blood glucose levels.
Measurement of fructosamine is especially useful in clinical scenarios where HbA1c results may be unreliable, such as in patients with haemoglobinopathies, altered red blood cell lifespan, or recent changes in therapy. By offering a shorter assessment window, the assay enables clinicians to evaluate the effectiveness of treatment adjustments more rapidly and make timely decisions in patient management. It is also beneficial in monitoring gestational diabetes and in cases requiring closer glycaemic control tracking.
The Biorex Diagnostics Fructosamine Assay is designed to deliver accurate, consistent, and reproducible results, supporting high standards of laboratory performance. Its robust methodology ensures reliable measurement across a wide range of samples, allowing laboratories to maintain confidence in analytical results. The assay is optimised for use in both routine diagnostics and specialised clinical applications, ensuring flexibility across laboratory environments.
Designed for seamless integration into automated workflows, the assay is compatible with widely used analysers including Hitachi 917, Olympus AU600/400/640/2700, and CA 180/270/400 Furuno/Daytona systems. This compatibility enhances laboratory efficiency, reduces manual handling, and supports high-throughput testing without compromising accuracy or reproducibility.
Key Features
- Quantitative measurement of fructosamine in serum and plasma
- Reliable marker for short-term glycaemic control
- High accuracy and reproducibility for consistent results
- Useful when HbA1c measurements are unreliable
- Compatible with major automated analyser platforms
Benefits
- Provides clinically meaningful short-term glucose monitoring
- Enables rapid assessment of treatment effectiveness
- Supports improved diabetes management and patient care
- Ensures consistent and reliable laboratory performance
- Enhances workflow efficiency with automated system compatibility
Routine use of the Biorex Diagnostics Fructosamine Assay allows laboratories to maintain high-quality diagnostic standards while supporting effective diabetes monitoring. Its precision, reliability, and ability to reflect short-term glycaemic changes make it an essential tool for clinical laboratories, hospital diagnostics, and research settings.
Contact Us for more information.